Review Article

Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Isolates from Moroccan Patients: Systematic Review

Table 1

Characteristics of studies included in the review.

Studies included in the reviewStudy areaStudy populationNo. of clinical MTB isolatesYear of collectionSex ratioAge rangeSample size

1Oudghiri et al. 2018 [26]Different cities in MoroccoConfirmed pulmonary TB7032010–21023.23–62 (80% were in the age group of 16–45 years old)New: 228
Previously treated (drug relapse and failure): 264
Under treatment: 33
Not available: 178

2Karimi et al. 2018 [27]Different cities located in the northern regionSuspected TB patients702013-20145.3616–72New: 42
Previously treated (drug relapse and failure): 14
Unknown treatment history: 14

3Ennassiri et al. 2017 [28]Different cities in MoroccoPulmonary TB3192013–20154.4Median age of 35.6.New: 88
Previously treated: 231

4Bentaleb et al. 2017 [29]Different cities in MoroccoConfirmed pulmonary TB67NANANANA

5Chaoui et al. 2014 [24]Different cities in MoroccoPulmonary TB500Isolates of MTB collected over a period of five yearsNANANA

6Zakham et al. 2013 [25]Different cities in MoroccoSuspected TB patients133NA2.6415–80 (median age 38)New: 100
Previously treated (drug relapse or failure, chronic cases): 33

NA: not available, TB: tuberculosis, and MTB: Mycobacterium tuberculosis.